Studies of protein C in thromboembolic disease

Bertina R. M., Broekmans A. W., Van der Linden I. K., Mertens K.: Protein C deficiency in a Dutch family with thrombotic disease. Thrombos. Haemost.48, 1, 1982. Bertina R. M., Broekmans A. W., Van Es-Krommenhoek T., Van Wijngaarden A.: The use of a functional assay for plasma protein C in the diagnosis of protein C deficiency. Thrombos. Haemost.50, 350, 1983. (Abstract). Branson H. E., Katz J., Marble R., Griffin J. H.: Inherited protein C deficiency and a coumarin-responsive chronic relapsing purpura fulminans syndrome in a neonate—Lancet. (In press). Broekmans A. W., Van der Linden I. K., Veltkamp J. J., Bertina R. M.: Prevalence of isolated protein C deficiency in patients with venous thrombotic disease and in the population. Thrombos. Haemost.50, 350, 1983. (Abstract). Broekmans A. W., Veltkamp J. J., Bertina R. M.: Congenital protein C deficiency and venous thromboembolism. A study of three Dutch families. New Engl. J. Med.309, 340, 1983. Broekmans A. W., Veltkamp J. J., Bertina R. M.: Clinical manifestations of isolated protein C deficiency. Thrombos. Haemost.50, 343, 1983. (Abstract). Comp P. C., Esmon C. T.: Generation of fibrinolytic activity by infusion of activated protein C into dogs. J. clin. Invest.68, 1221, 1981. Comp P. C., Nixon R. R., Esmon C. T.: Determination of functional levels of protein C, an antithrombotic protein, using thrombin-thrombomodulin complex. Blood63, 15, 1984. Esmon C. T., Esmon N. L., Harris K. W.: Complex formation between thrombin and thrombomodulin inhibits both thrombin-catalyzed fibrin formation and factor V activation. J. biol. Chem.257, 7944, 1982. Esmon C. T., Owen W. G.: Identification of an endothelial cell cofactor for thrombincatalyzed activation of protein C. Proc. nat. Acad. Sci (Wash.)78, 2249, 1981. Esmon N. L., Owen W. G., Esmon C. T.: Isoiation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C. J. biol. Chem.257, 859, 1982. Grifein J. H., Evatt B., Zimmerman T. S., Kleiss A. J., Wideman C.: Deficiency of protein C in congenital thrombotic disease. J. clin. Invest.68, 1370, 1981. Griffin J. H., Mosher D. F., Zimmerman T. S., Kleiss A. J.: Protein C, an antithrombotic protein, is reduced in hospitalized patients with intravascular coagulation. Blood60, 261, 1982. Kisiel W.: Human plasma protein C: isolation, characterization and mechanism of activation by α-thrombin. J. clin. Invest.64, 761, 1979. Kisiel W., Ericsson L. H., Davie E. W.: Proteolytic activation of protein C from bovine plasma. Biochemistry15, 4893, 1976. Mammen E. F., Thomas W. R., Seegers W. H.: Activation of purified prothrombin to auto-prothrombin I or autoprothrombin II (platelet cofactor III) or autoprothrombin II-A. Thrombos. Diathes. haemorrh. (Stuttg.)5, 218, 1960. Mannucci P. M., Vigano S.: Deficiencies of protein C, an inhibitor of blood coagulation. Lancetii, 463, 1982. Marlar R. A., Kleiss A. J., Griffin J. H.: Mechanism of action of human activated protein C, a thronbin-dependent anncoagulant enzyme. Blood59, 1067, 1982. Owen W. G., Esmon C. T.: Functional properties of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. J. biol. Chem.256, 5532, 1981. Sala N., Owen W. G., Collen D.: Functional assay for protein C in human plasma. Thrombos Haemost.50, 352, 1983 (Abstract). Seegers W. H., McCoy L. E., Groben H. D., Sakuragawa N., Agrawal B. B. L.: Purification and some properties of autoprothrombin H-A: an anticoagulant perhaps also related to fibrinolysis. Thrombos. Res.1, 443, 1972. Stenelo J. A.: A new vitamin K-dependent protein. Purification from bovine plasma and preliminary characterization. J. biol. Chem.251, 355, 1976. Suzuki K., Nishioka J., Hashimoto S.: Protein C inhibitor. Purification from human plasma and characterization. J. biol. Chem.258, 163, 1983. Walker F. J.: Regulation of activated protein C by protein S: the role of phospholipid in factor Va inactivation. J. biol. Chem.256, 11128, 1981.